US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

255.55

+5.152.06%

Volume:91.18K

Turnover:23.30M

Market Cap:504.58M

PE:- -

High:259.40

Open:255.78

Low:250.92

Close:250.40

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.00

T/O Rate:4.62%

Dividend:1.00

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Barclays downgrades Scholar Rock on valuation after FDA approval

Worldwide Healthcare Trust to Publish August 2026 Monthly Fact Sheet

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Caliway's Abdominal Fat Reduction Drug Clears US FDA Review

MT Newswires Live

Roth MKM Remains a Buy on Insmed (INSM)

QuantaMatrix Wins Shareholder Backing for Broad Bio-Healthcare Expansion

Kolmar Korea to Brief Global Investors at Daiwa Consumer and Healthcare Conference in Hong Kong

EBR Systems Says US FDA Begins Pre-Approval Inspection of California Manufacturing Facility

MT Newswires Live

FDA begins pre-approval inspection of EBR Systems’ new cardiac device plant

Flexible Workers Urged to Join Employee Medical Insurance as China's Gig Workforce Surpasses 200 Million

Flexible Workers Encouraged to Enroll in Employee Medical Insurance as National Flexible Workforce Tops 200 Million

Wall Street Analysts Are Bullish on Top Real Estate Picks

CurveBeam AI Wins FDA Clearance for CT-Based Bone Density Platform

Health Care up on Rotation into Less Fuel-Sensitive Sectors

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live

60 Degrees Advances Babesiosis Treatment With FDA Submission

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":255.551,"timestamp":1789573513686,"preClose":250.4,"halted":0,"volume":91179,"delay":0,"changeRate":0.02057108626198076,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Trading","change":5.151,"latestTime":"09-16 11:45:26 EDT","open":255.78,"high":259.395,"low":250.92,"amount":23296822.60455,"amplitude":0.033846,"askPrice":256.75,"askSize":30,"bidPrice":255.91,"bidSize":130,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.003919,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":254.8128,"preClose":250.4,"latestTime":"09:28 EDT","volume":4289,"amount":1082884.5326099999,"timestamp":1789565312693,"change":4.4128,"changeRate":0.017623,"amplitude":0.012511},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":1.000565,"impliedVol":0.9268,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.000565,"shares":1974486,"dividePrice":1.0016,"high":259.395,"amplitude":0.033846,"preClose":250.4,"low":250.92,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":255.551,"committee":0.625,"eps":0,"divideRate":0.003919,"volume":91179,"delay":0,"ttmEps":0,"open":255.78,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDIG","IBB","TACU","LFSC","FRTY","PINK","SYNB","TBXU","TSPA","TECB","LABU","PSCH","GNMX","MEDI","BBP","RSPH","MRNY","BMED","IYH","XLVX","IDNA","GDOC","NVIB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610402","title":"Worldwide Healthcare Trust to Publish August 2026 Monthly Fact Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610402?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:22","pubTimestamp":1789460560,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has shared an update. Worldwide Healthcare Trust PLC has announced that its monthly fact sheet for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-to-publish-august-2026-monthly-fact-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-to-publish-august-2026-monthly-fact-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG","LABU","LU0128526141.USD","LU0029874061.USD","BK4137","BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667361032","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2667361032","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667361032?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:20","pubTimestamp":1789460400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0731 GMT - Medacta should continue to book above-market growth r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4581","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667130617","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667130617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667130617?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:00","pubTimestamp":1789459250,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Tonix Pharma (TNXP) and So...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-tonix-pharma-tnxp-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-tonix-pharma-tnxp-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","BK4583","BK4198","BK4585","LU0029874061.USD","BK4139","SOLV","BK4581","BK4137","LU0128526141.USD","XLV","HCSG","BK4588","BFLY","BK4082","TNXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612762","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667612762?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:30","pubTimestamp":1789457409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF) and LeonaBio (LONA) wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-338?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-338?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","BK4139","TLPPF","TLX","HCSG","BK4588","LONA","LU0128526141.USD","XBI","XLV","LABU","LU0029874061.USD","BK4007","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","09637","BK4588","BK1191","159938","VXUS","09939","BK1574","BK4585","BK1515","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667816616","title":"Caliway's Abdominal Fat Reduction Drug Clears US FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667816616","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667816616?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:05","pubTimestamp":1789448708,"startTime":"0","endTime":"0","summary":"Caliway Biopharmaceuticals  said the U.S. FDA's 30-day review period for an amended Phase 3 protocol for CBL-514 in abdominal subcutaneous fat reduction has been cleared.The SUPREME-02 study will enroll about 320 participants and assess CBL-514's safety and effectiveness in reducing abdominal fat, according to a Monday filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667615064","title":"Roth MKM Remains a Buy on Insmed (INSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667615064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667615064?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:45","pubTimestamp":1789447518,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Adam Walsh reiterated a Buy rating on Insmed today and set a price target of $198.00. Walsh covers the Healthcare sector, focusing...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","LU0320765992.SGD","INSM","LU0053671581.USD","BK4588","LU0889565916.HKD","LU0109394709.USD","XBI","XLV","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667285690","title":"QuantaMatrix Wins Shareholder Backing for Broad Bio-Healthcare Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2667285690","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667285690?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:14","pubTimestamp":1789438446,"startTime":"0","endTime":"0","summary":"QuantaMatrix, Inc. ( ($KR:317690) ) has provided an announcement. QuantaMatrix, Inc. is a bio-healthcare company expanding from its core diagnostic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quantamatrix-wins-shareholder-backing-for-broad-bio-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quantamatrix-wins-shareholder-backing-for-broad-bio-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","CGCV","BK4550","BK4137","VHT","IXJ","LU0128526141.USD","NOBL","BK4581","BK4588","LABU","TCAF","BK4585","HCSG","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667692903","title":"Kolmar Korea to Brief Global Investors at Daiwa Consumer and Healthcare Conference in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667692903","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667692903?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:43","pubTimestamp":1789433032,"startTime":"0","endTime":"0","summary":"KOLMAR KOREA CO. LTD ( ($KR:161890) ) has issued an announcement. Kolmar Korea Co. Ltd will hold in-person investor relations meetings in Hong Kong...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-korea-to-brief-global-investors-at-daiwa-consumer-and-healthcare-conference-in-hong-kong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-korea-to-brief-global-investors-at-daiwa-consumer-and-healthcare-conference-in-hong-kong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","HCSG","LABU","XLV","ISBC","XBI","BK4588","LU0029874061.USD","BK4137","LU0128526141.USD","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691420","title":"EBR Systems Says US FDA Begins Pre-Approval Inspection of California Manufacturing Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691420","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691420?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:56","pubTimestamp":1789430215,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  started its pre-approval inspection of the company's new manufacturing facility in Santa Clara, California, marking a key step in the regulatory process, according to a Tuesday filing with the Australian bourse.The company still anticipates receiving US FDA approval for the facility by the end of the year, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EBR.AU","LABU","BK7007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691207","title":"FDA begins pre-approval inspection of EBR Systems’ new cardiac device plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691207?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:53","pubTimestamp":1789429998,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, Inc., developer of the w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-begins-pre-approval-inspection-of-ebr-systems-new-cardiac-device-plant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-begins-pre-approval-inspection-of-ebr-systems-new-cardiac-device-plant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129994098","title":"Flexible Workers Urged to Join Employee Medical Insurance as China's Gig Workforce Surpasses 200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1129994098","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129994098?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:50","pubTimestamp":1789429829,"startTime":"0","endTime":"0","summary":"China's legislative authority has taken a significant step to broaden healthcare coverage for its expanding gig economy workforce. The Standing Committee of the 14th National People's Congress passed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145552199","title":"Flexible Workers Encouraged to Enroll in Employee Medical Insurance as National Flexible Workforce Tops 200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1145552199","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145552199?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:40","pubTimestamp":1789429229,"startTime":"0","endTime":"0","summary":"A new legal provision is set to encourage self-employed individuals without hired staff, part-time workers not covered by employer-based employee basic medical insurance, and other flexible workers...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691769","title":"Wall Street Analysts Are Bullish on Top Real Estate Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691769?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:40","pubTimestamp":1789429205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on American Healthcare REIT, Inc. (AHR) and GPT Group ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-39?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-39?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","YLDW","BK4225","IVRA","LABU","REIT","PSCF","RJMG","BK4585","XLV","DFRA","BK4588","GPT","BPRE","AHR","BK4581","IQRA","MDIV","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667699733","title":"CurveBeam AI Wins FDA Clearance for CT-Based Bone Density Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2667699733","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667699733?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:45","pubTimestamp":1789425907,"startTime":"0","endTime":"0","summary":"Curvebeam AI Ltd. ( ($AU:CVB) ) has provided an update. CurveBeam AI has secured U.S. FDA 510(k) clearance for its CT-based bone mineral density te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curvebeam-ai-wins-fda-clearance-for-ct-based-bone-density-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curvebeam-ai-wins-fda-clearance-for-ct-based-bone-density-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTOC","VTHR","AGIX","BK4588","BK4585","LABU","AIPO","CHAT","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696065","title":"Health Care up on Rotation into Less Fuel-Sensitive Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696065?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:05","pubTimestamp":1789423500,"startTime":"0","endTime":"0","summary":"Health-care companies rose as traders rotated into sectors less susceptible to rising fuel prices and interest rates.Wegovy maker Novo Nordisk plans to rebrand itself as Novo, betting a shorter name will help it resonate more with consumers as it competes with rival Eli Lilly.AstraZeneca said its new breast-cancer pill missed the key goal of slowing the disease from worsening in a late-stage clinical trial. Shares of the British drug maker still gained.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966776","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:10","pubTimestamp":1789420212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and ArriVent BioPharma, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","CANC","XBI","PTH","BK4581","AVBP","BBH","IE0009354923.USD","RVMD","LU0109394709.USD","LABU","BK4588","IE00BJT1NW94.SGD","XLV","BK4139","IDNA","IE00B4R5TH58.HKD","LU0029874061.USD","LU0128526141.USD","HCSG","LU0889565916.HKD","IE00B2B36J28.USD","BK4137","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695932","title":"Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695932","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695932?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418122,"startTime":"0","endTime":"0","summary":"Revolution Medicines  said Monday that the US Food and Drug Administration has given breakthrough therapy designation to Rasonque plus chemotherapy to treat pancreatic cancer.The company said Rasonque was recently approved by the US FDA to treat adults with metastatic pancreatic cancer who have received at least one systemic therapy or who are not candidates for multiagent systemic therapy.Revolution said the use of Rasonque plus chemotherapy for treatment-naive metastatic pancreatic adenocarcinoma is still investigational, with safety and efficacy not yet established.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","CANC","PTH","BBH","IE0009354923.USD","RVMD","LU0109394709.USD","LABU","BK4588","IE00BJT1NW94.SGD","BK4139","IDNA","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667169544","title":"60 Degrees Advances Babesiosis Treatment With FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2667169544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667169544?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:32","pubTimestamp":1789417923,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an announcement. On September 12, 2026, 60 Degrees Pharmaceuticals submitted a Statement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-advances-babesiosis-treatment-with-fda-submission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-advances-babesiosis-treatment-with-fda-submission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","LABU","SXTP","PRTO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":4,"totalSize":414,"code":"91000000","status":"200"}]}}